Systemically, the sustained presence of elevated cytokines that can drive tumor immune surveillance such as IL-1044, GM-CSF, IL-12, and IFNγ was intrinsically associated with early onset and sustained tumor engraftment of highly activated CD8+ T cells, including bifunctional IFNγ and TNFα producers. This evidence concerns the gene CSF2 and neoplasm.